设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 3 期 第 16 卷

金柴清肝汤联合西药治疗肝胃郁热型反流性食管炎的临床疗效研究

Clinical effect of Jinchai Qinggan decoction combined with western medicine on reflux esophagitis of depression-heat in liver and stomach type

作者:黄秋思1郭丹丹2姚丹1王楠楠1张金良1

英文作者:Huang Qiusi1 Guo Dandan2 Yao Dan1 Wang Nannan1 Zhang Jinliang1

单位:1黑龙江中医药大学附属第二医院肝脾胃病房,哈尔滨150010;2黑龙江中医药大学附属第二医院心病一病房,哈尔滨150010

英文单位:1Liver Spleen Stomach Ward the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin 150010 China; 2the First Cardiac Ward the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine Harbin 150010 China

关键词:反流性食管炎;金柴清肝汤;肝胃郁热

英文关键词:Refluxesophagitis;JinchaiQinggandecoction;Depression-heatinliverandstomach

  • 摘要:
  • 目的 探讨金柴清肝汤联合西药治疗肝胃郁热型反流性食管炎(RE)的临床疗效。方法 回顾性分析20188月至20197月黑龙江中医药大学附属第二医院收治的60例肝胃郁热型RE患者的临床资料,根据不同治疗方案将其分为对照组和观察组,各30例。对照组予马来酸曲美布汀片、雷贝拉唑钠肠溶片治疗,观察组在对照组基础上予金柴清肝汤治疗,2组均连续治疗4周。比较2组治疗前后反流性疾病问卷(RDQ)、内镜检查评分。观察2组临床疗效、内镜检查疗效,记录随访期间患者胃肠道症状及RE复发情况。结果 治疗后,2RDQ及内镜检查评分均低于治疗前,且观察组均低于对照组[(13.8±2.5)分比(21.2±4.9)分、(0.51±0.12)分比(1.43±0.41)分],差异均有统计学意义(均P0.05)。观察组临床总有效率、内镜检查总有效率均高于对照组[93.3%28/30)比80.0%24/30)、86.7%26/30)比70.0%21/30)](均P0.05)。随访期间,2组患者胃肠道症状发生率比较,差异无统计学意义(P0.05),观察组复发率低于对照组,差异有统计学意义(P0.05)。结论 金柴清肝汤联合西药治疗肝胃郁热型RE效果显著,可有效改善患者临床症状,降低复发率。

  • Objective To investigate the clinical effect of Jinchai Qinggan decoction combined with western medicine on reflux esophagitis (RE) of depression-heat in liver and stomach type. Methods From August 2018 to July 2019, clinical data of 60 patients with RE of depression-heat in liver and stomach type admitted to the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine were retrospectively analyzed. According to different treatment regimens, they were divided into the control group  and the observation group, with 30 cases in each group. The control group was treated with trimebutine maleate tablets and sodium rabeprazole enteric-coated tablets, and the observation group was treated with Jingchai Qinggan decoction on the basis of the control group. Both groups were treated for 4 weeks. The reflux diagnostic questionnaire(RDQ) score and endoscopic score were compared between the two groups before and after treatment. The clinical curative effect and endoscopic curative effect in two groups were observed, and the incidence of gastrointestinal symptoms and recurrence of RE during follow-up period were recorded. Results After treatment, RDQ score and endoscopic score of the two groups were lower than those before treatment, and those of the observation group were lower than those of the control group [(13.8±2.5 vs 21.2±4.9,0.51±0.12 vs 1.43±0.41)](all P<0.05). The total clinical effective rate and total endoscopic effective rate of the observation group were higher than those of the control group 93.3%28/30 vs 80.0%24/30, 86.7%26/30 vs 70.0%21/30)](both P<0.05). During follow-up period, there was no significant difference in the incidence of gastrointestinal symptoms between the two groupsP>0.05, and the recurrence rate of the observation group was lower than that of the control groupP<0.05. Conclusions Jinchai Qinggan decoction combined with western medicine is effective in treating RE of depression-heat in liver and stomach type. It can effectively improve clinical symptoms and reduce the recurrence rate. 1px; text-align:justify; text-justify:inter-ideograph; mso-pagination:none; font-size:14px; mso-bidi-font-size:15px; font-family:"Calibri","sans-serif"; mso-fareast-font-family:宋体; mso-bidi-font-family:"Times New Roman"; mso-font-kerning:1px;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:13px; mso-ansi-font-size:13px; mso-bidi-font-size:13px; mso-ascii-font-family:Calibri; mso-fareast-font-family:宋体; mso-hansi-font-family:Calibri; mso-font-kerning:0;}  /* Page Definitions */  @page {mso-page-border-surround-header:no; mso-page-border-surround-footer:no;} @page Section1 {size:816px 1056px; margin:96px 120px 96px 120px; mso-header-margin:48px; mso-footer-margin:48px; mso-paper-source:0;} div.Section1 {page:Section1;} -->

    1Liver Spleen Stomach Ward, the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150010, China; 2the First Cardiac Ward, the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150010, China


copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭